Abstract:Martin Kulke, 1 Felix Nagel, 1 Lukas Schulig, 2 Norman Geist, 1 Marcel Gabor, 1 Julia Mayerle, 3 Markus M Lerch, 4 Andreas Link, 2 Mihaela Delcea 1 1 Institute of Biochemistry, University of Greifswald, Greifswald, Germany; 2 Institute of Pharmacy, University of Greifswald, Greifswald, Germany; 3 Department of Medicine II, Ludwig-Maximilian University of Munich, Munich, Germany; 4 Department of Medicine a, University Medicine Greifswald, Greifswald, Germany Correspondence: Mihaela Delcea; Martin Kulke Institute of Biochemistry, University of Greifswald, Felix-Hausdorff-Straße 4, Greifswald, 17487, Germany Tel +49 3834 420 4423 Fax +49 3834 420 4377 Email ; Purpose: Although strongly related, the pathophysiological effect of the N34S mutation in the serine protease inhibitor Kazal type 1 (SPINK1) in chronic pancreatitis is still unknown. In this study, we investigate the conformational space of the human cationic trypsin-serine protease inhibitor complex. Methods: Simulations with molecular dynamics, replica exchange, and transition pathway methods are used. Results: Two main binding states of the inhibitor to the complex were found, which explicitly relate the influence of the mutation site to conformational changes in the active site of trypsin. Conclusion: Based on our result, a hypothesis is formulated that explains the development of chronic pancreatitis through accelerated digestion of the mutant by trypsin. Keywords: trypsin, molecular dynamics simulations, replica exchange, transition path sampling, umbrella sampling Pancreatitis is an inflammatory disorder of the pancreas. While acute and chronic pancreatitis were previously viewed as separated diseases, today they are regarded as a continuum, with nearly 30% of the patients exhibiting overlapping phenotypes that manifest as recurrent pancreatitis. 1 Chronic pancreatitis (CP) develops from recurrent episodes of acute pancreatitis that lead to fibrosis, exocrine pancreatic insufficiency and diabetes. While initial triggers for pancreatitis are diverse, almost all of them result in premature activation of trypsin and subsequently other proteases in pancreatic acinar cells. Therefore, pancreatitis is considered to be an autodigestive disorder caused by trypsin auto-activation, which is also supported by numerous mutations in the PRSS1 gene coding for human cationic trypsin (TRY1). 2 , 3 The serine protease inhibitor Kazal-type 1 (SPINK1, also known as PSTI or TATI) represents the first line of defense against the trypsin auto-activation cascade by potently binding and inhibiting active trypsin. The inhibitor has a size of 6.2 kDa and is co-located with trypsinogen and other zymogens in storage organelles called zymogen granules of pancreatic acinar cells. The c.101A>G point mutation is the most common variant of the SPINK1 gene, which results in a p.N34S amino acid substitution and represents one of the most clinically relevant risk factors for chronic pancreatitis with almost 10% of the patients carrying the mutation, compared to 1% of the healthy population. 4–6 Although the p.N34S mutation was identified over two decades ago and was subjected to many additional studies, the mechanism of action of this variant remains enigmatic to this day. 4 , 5 , 7 , 8 Hypotheses regarding the disease relevant function of this variant ranged from reduced inhibitory activity, misfolding, reduced expression or secretion to reduced proteolytic stability, structural alterations and secondary trigger mechanisms. While most of the aforementioned hypotheses have now been refuted, very little is known about the SPINK1 structure. 9–16 Patient studies revealed that the p.N34S mutation alone is not sufficient to develop chronic pancreatitis, but must be combined with additional risk factors. 17–19 It can therefore be assumed that the p.N34S mutation does not lead to a complete destruction of functional SPINK1, but rather reduces either the kinetic properties or the number of correctly folded SPINK1 molecules. In an earlier study, we showed differing secondary structures of SPINK1 wild type (WT) and the N34S mutant by circular dichroism (CD) spectroscopy as well as different secondary structures at lower pH values. 20 </s -Abstract Truncated-

Substrate specificity of human chymotrypsin-like protease (CTRL) characterized by phage display-selected small-protein inhibitors

The High-Affinity Chymotrypsin Inhibitor Eglin C Poorly Inhibits Human Chymotrypsin-Like Protease: Gln192 and Lys218 Are Key Determinants

Novel chymotrypsin C (CTRC) variants from real-world genetic testing of pediatric chronic pancreatitis cases

Surface loops of trypsin-like serine proteases as determinants of function

Tyrosine Sulfation of Human Trypsin Steers S2’ Subsite Selectivity towards Basic Amino Acids

New, sensitive fluorogenic substrates for human cathepsin G based on the sequence of serpin-reactive site loops

Binding of amino acid side-chains to S 1 cavities of serine proteinases 1 1Edited by R. Huber

ER stress-associated CTRC mutants decrease stimulated pancreatic zymogen secretion through SIRT2-mediated microtubule dysregulation

Identification of the protease inhibitory domain of Trichinella spiralis novel cystatin (TsCstN)

Binding of amino acid side-chains to S1 cavities of serine proteinases

Cystine-knot peptide inhibitors of HTRA1 bind to a cryptic pocket within the active site region

Probing prime substrate binding sites of human dipeptidyl peptidase-IV using competitive substrate approach.

Deviation of Trypsin Activity Using Peptide Conformational Imprints

In vitro, in silico and crystallographic-based identification of serine protease inhibitors

Modeling protease-sensitive human pancreatic lipase mutations in the mouse ortholog

Cold adaptation, ca2+ dependency and autolytic stability are related features in a highly active cold-adapted trypsin resistant to autoproteolysis engineered for biotechnological applications

Molecular Insight into Chymotrypsin Inhibitor 2 Resisting Proteolytic Degradation

A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies

Chymotrypsin activity signals to intestinal epithelium by protease‐activated receptor‐dependent mechanisms

Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G

Conformation of the primary binding loop folded through an intramolecular interaction contributes to the strong chymotrypsin inhibitory activity of the chymotrypsin inhibitor from Erythrina variegata seeds